Skip to main content

Fluens Medical

Fluens Medical is developing a minimally invasive implantable device that continuously redirects ascitic fluid back into the vasculature, preserving it within the body rather than draining it externally. The bio-inspired approach aims to reduce hospital visits from repeated paracentesis procedures and serve as a bridge to liver transplant for patients with decompensated cirrhosis.

Traction –/10
Houston, United States · HQ
350+ followers
  • Medical Devices
  • Healthcare Technology
  • Hardware
Updated 4 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Ascites, the most common decompensation event in cirrhosis, affects a large share of chronic liver disease patients and carries a severe prognosis, with 40% developing hepatorenal syndrome and 80% mortality within three months. Existing treatments require frequent paracentesis procedures, causing repeated hospital visits and suboptimal long-term outcomes.

Solution

Fluens Medical is developing an implantable device that continuously and safely preserves ascitic fluid within the body, unlike existing approaches that drain it. The proprietary, minimally invasive implant redirects ascitic fluid back to its source—the vasculature—using a bio-inspired approach that leverages the body's natural pathways. This continuous management of fluid balance aims to reduce hospital visits due to paracentesis and improve long-term outcomes. The device is positioned as a bridge to liver transplant for patients with decompensated cirrhosis.

Target Audience

The primary users are hepatologists, interventional radiologists, and transplant centers managing patients with decompensated cirrhosis and ascites, as well as the cirrhosis patient population who require ongoing fluid management.

Features

  • Minimally invasive implantable device designed for continuous ascitic fluid management
  • Bio-inspired technology that redirects fluid to the vasculature rather than draining it externally
  • Continuous fluid preservation within the body to restore natural fluid balance
  • Intended to reduce or eliminate the need for repeated paracentesis procedures
  • Designed as a bridge therapy for patients awaiting liver transplantation
This profile is AI-generated and may contain inaccuracies.